反応 #2329010

ord-0171bb6dfd914455bd397d0af991b7a6

反応方程式

CC(C)(C)[O-].[K+]
potassium t-butoxide
C1CCOC1
THF
N#Cc1ccc(F)cc1Cl
4-fluoro-2-chloro-benzonitrile
C1CCOC1
THF
OC1CCC(O)C1
3-hydroxy cylcopentanol
CC1CCC(Oc2ccc(C#N)c(Cl)c2)C1
title compound
収率 52.0%
CC1CCC(Oc2ccc(C#N)c(Cl)c2)C1
2-Chloro-4-(3-methyl-cyclopentyloxy)-benzonitrile
収率 52.0%

溶媒

反応条件

温度
5°CELSIUS
詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他vial fitted with a septa
  2. 2
    その他cap
  3. 3
    workup.STIRRINGThe reaction was stirred at 5° C. for 3 h
  4. 4
    温度to warm to room temperature
  5. 5
    workup.STIRRINGstirred overnight at room temperature
  6. 6
    温度The reaction mixture was cooled to 0° C.
  7. 7
    その他quenched with 2 mL of water
  8. 8
    workup.ADDITIONdiluted with 2 mL of methyl tert-butyl ether
  9. 9
    workup.STIRRINGThe vial was shaken vigourously
  10. 10
    その他to separate
  11. 11
    その他The aqueous layer was removed with a pipette
  12. 12
    洗浄the organic layer washed with another 2 mL of water
  13. 13
    乾燥The organic phase was dried (MgSO4)
  14. 14
    濃縮concentrated in vacuo
  15. 15
    その他the residue purified by reverse phase HPLC (Shimadzu)

実験手順

A 1.0 M solution of potassium t-butoxide in t-butanol (0.3 mL) was added to a 8 mL vial fitted with a septa cap containing 0.3 mL of dry THF and 30 mg (0.3 mmoles) of 3-hydroxy cylcopentanol at 5° C. The mixture was stirred for 0.5 h at 5° C., after which time 0.3 mL of a 1.0 M THF solution of 4-fluoro-2-chloro-benzonitrile was added. The reaction was stirred at 5° C. for 3 h and then allowed to warm to room temperature and stirred overnight at room temperature. The reaction mixture was cooled to 0° C., and quenched with 2 mL of water, diluted with 2 mL of methyl tert-butyl ether. The vial was shaken vigourously and the phases allowed to separate. The aqueous layer was removed with a pipette, and the organic layer washed with another 2 mL of water. The organic phase was dried (MgSO4), concentrated in vacuo, and the residue purified by reverse phase HPLC (Shimadzu) to give 36 mg (52%) of the title compound. GC/MS: 235 (M/Z for C13H14ClNO).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07670613B2uspto-grants-2010_03